Metabolic Crosstalk in Diabetic Kidney Disease: Synergistic Effects of Glucotoxicity and Lipotoxicity

Junying Cao,1 Zhihua Dun,1 Dandan Tian,1 Zhihui Qiao,1 Yuehua Wang1,2 1The Second Affiliated Hospital of Hebei University of Chinese Medicine (Hebei Province Seventh People’s Hospital), Dingzhou, Hebei, 073000, People’s Republic of China; 2College of Integrated Chinese and Western Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, 050200, People’s Republic of ChinaCorrespondence: Yuehua Wang, College of Integrated Chinese and Western Medicine, Hebei University of Chinese Medicine, No. 3 Xingyuan Road, Shijiazhuang, Hebei, 050200, People’s Republic of China, Email [email protected]: Diabetic kidney disease (DKD) affects approximately 40% of patients with diabetes and remains the leading cause of end-stage renal disease globally, posing a critical public health challenge. While hyperglycemia has long been considered the primary driver, the persistence of residual renal risk despite intensive glycemic control highlights a critical gap in our understanding of the disease’s multifaceted metabolic origins. This review addresses this gap by shifting the focus beyond the “gluco-centric” paradigm to the synergistic lethality of “glucolipotoxicity.” We synthesize evidence showing how insulin resistance acts as a central hub connecting glucotoxicity and lipotoxicity, triggering a self-perpetuating vicious cycle of injury. Specifically, we dissect the molecular crosstalk across key pathogenic nodes, including the TXNIP-mTOR axis suppressing autophagy, DAG-PKC signaling driving insulin resistance, and the activation of the NLRP3 inflammasome. These intersecting pathways converge to accelerate oxidative stress, mitochondrial dysfunction, and fibrosis. We conclude by discussing the clinical implications of this metabolic framework, emphasizing how emerging multi-target therapies, such as SGLT2 inhibitors and GLP-1 receptor agonists, offer a translational pathway from mechanistic insights to precision medicine for preserving renal function.Keywords: diabetic kidney disease, glucolipotoxicity, insulin resistance, lipotoxicity, oxidative stress

Authors

Institutions

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2026-03-01
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metabolic Crosstalk in Diabetic Kidney Disease: Synergistic Effects of Glucotoxicity and Lipotoxicity

Tian Maikel Hardiansah D, Wang Y, Cao J, Qiao Z et al.
SHILAP Revista de lepidopterología
Chronic Kidney Disease and Diabetes
article

Metabolic Crosstalk in Diabetic Kidney Disease: Synergistic Effects of Glucotoxicity and Lipotoxicity

Tian Maikel Hardiansah D, Wang Y, Cao J, Qiao Z, Dun Z
article en

Abstract

Junying Cao,1 Zhihua Dun,1 Dandan Tian,1 Zhihui Qiao,1 Yuehua Wang1,2 1The Second Affiliated Hospital of Hebei University of Chinese Medicine (Hebei Province Seventh People’s Hospital), Dingzhou, Hebei, 073000, People’s Republic of China; 2College of Integrated Chinese and Western Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, 050200, People’s Republic of ChinaCorrespondence: Yuehua Wang, College of Integrated Chinese and Western Medicine, Hebei University of Chinese Medicine, No. 3 Xingyuan Road, Shijiazhuang, Hebei, 050200, People’s Republic of China, Email [email protected]: Diabetic kidney disease (DKD) affects approximately 40% of patients with diabetes and remains the leading cause of end-stage renal disease globally, posing a critical public health challenge. While hyperglycemia has long been considered the primary driver, the persistence of residual renal risk despite intensive glycemic control highlights a critical gap in our understanding of the disease’s multifaceted metabolic origins. This review addresses this gap by shifting the focus beyond the “gluco-centric” paradigm to the synergistic lethality of “glucolipotoxicity.” We synthesize evidence showing how insulin resistance acts as a central hub connecting glucotoxicity and lipotoxicity, triggering a self-perpetuating vicious cycle of injury. Specifically, we dissect the molecular crosstalk across key pathogenic nodes, including the TXNIP-mTOR axis suppressing autophagy, DAG-PKC signaling driving insulin resistance, and the activation of the NLRP3 inflammasome. These intersecting pathways converge to accelerate oxidative stress, mitochondrial dysfunction, and fibrosis. We conclude by discussing the clinical implications of this metabolic framework, emphasizing how emerging multi-target therapies, such as SGLT2 inhibitors and GLP-1 receptor agonists, offer a translational pathway from mechanistic insights to precision medicine for preserving renal function.Keywords: diabetic kidney disease, glucolipotoxicity, insulin resistance, lipotoxicity, oxidative stress

SHILAP Revista de lepidopterología
Pediatric Nephrology of Alabama (US)
Good health and well-being
Openalex Percentile: Top 3%
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Metabolic Crosstalk in Diabetic Kidney Disease: Synergistic Effects of Glucotoxicity and Lipotoxicity — Tian Maikel Hardiansah D, Wang Y, et al. · SHILAP Revista de lepidopterología (2026) | TGRS Research Map | TGRS